MEDICINAL CANNABIS

What does a Kamala Harris Vice Presidency mean for cannabis legalisation?

Finfeed Archived Aug 31, 2020

Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalization?

No mention of cannabis legalisation at US Democrat National Convention

Finfeed Archived Aug 28, 2020

Despite the pro-cannabis atmosphere in 2019 during the Democrat primaries and Biden's and Harris's evolving stances on cannabis, there were no comments on cannabis legalization in the 2020 DNC.

Podcast: The future of the cannabis industry and what investors should expect

Finfeed Archived May 27, 2020

Here to speak with Finfeed today about the ups and downs of the cannabis industry, cannabis in Canada and what he sees is the future of the cannabis industry is COO and director of Embark Health, Mike Curtis.

MMJ Group upbeat about Embark Health’s first B2B sale

Finfeed Archived May 11, 2020

MMJ investee Embark Health has signed the group’s first business to business (B2B) sale of Bulk Bubble Hash.

Will 2021 be the year the cannabis industry makes a comeback?

Finfeed Archived May 08, 2020

The bubble has officially burst when it comes to the global cannabis market, yet it seems increasingly likely that 2021 will be a rebound year industry — once the coronavirus pandemic eases and markets begin to rally — but the path to profitability won't be easy.

The world in medical cannabis and weed this week

Finfeed Archived May 01, 2020

The final week in April has proven to be a big week in the cannabis sector, with several global milestones expected in May.

Embark Health licence approvals bode well for MMJ Group

Finfeed Archived Apr 28, 2020

MMJ Group has provided an update on licence approvals for Embark Health, whose BC facility has now received all occupancy and business licences required from the city of Delta, BC, and will commence the extraction of cannabis in April 2020.

Cannabis companies unite to help combat COVID-19

Finfeed Archived Apr 28, 2020

Canada’s WeedMD is pivoting to help the broader health sector as COVID-19 continues to put lives in danger.

MMJ net tangible asset value implies share price upside of 150%

Finfeed Archived Apr 09, 2020

ASX cannabis stock news: Global cannabis investment group MMJ (ASX:MMJ) which owns a portfolio of cannabis investments is trading at a sharp discount to its intrinsic value.

Could This ASX Cannabis Stock Soar Amid the Coronavirus?

Finfeed Archived Mar 20, 2020

As fears surrounding the Coronavirus drive the markets down, one ASX-listed pot stock could triumph amid the COVID-19 crisis.

Can cannabis companies rebound after COVID-19?

Finfeed Archived Mar 17, 2020

Will cannabis stocks survive the Coronavirus? The strong will survive and there could be bargains to be had.

MMJ extends its Harvest One Cannabis investment

Finfeed Archived Mar 12, 2020

Global cannabis investment company MMJ Group Holdings Limited (ASX:MMJ) today announced that it has extended a loan to Harvest One Cannabis Inc. (TSX-V: HVT).

MMJ’s Canadian cannabis investment Weed Me attracts new capital

Finfeed Archived Mar 10, 2020

Weed Me, one of the largest investments within MMJ Group’s cannabis and hemp portfolio, has completed a C$2.5 million capital raising.

MMJ’s Harvest One flags turnaround in 2020

Finfeed Archived Mar 09, 2020

MMJ Group Holdings Limited (ASX:MMJ) provides an update on one of its largest investments, Harvest One Cannabis Inc. (TSX-V: HVT).

Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint

Next Investors Archived Mar 04, 2020

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

Creso Pharma agreement signals entry into Scandinavia

Finfeed Archived Mar 03, 2020

Creso Pharma Limited (ASX:CPH) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

Creso Pharma set to expand human health product line with technological breakthrough

Finfeed Archived Feb 06, 2020

Creso Pharma has achieved a key technological milestone, developing its first water-soluble microgranulated hemp plant granules product as an expansion of its cannaQIX® human health product line.

CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough

Next Investors Archived Feb 06, 2020

Hot on the heels of major developments in human and animal health, Creso Pharma (ASX:CPH) has achieved another key milestone: a technological breakthrough that will expand its cannaQIX® human health product line,

Medicinal Cannabis